EP2214769A1 - Non-invasively adjustable drainage device - Google Patents
Non-invasively adjustable drainage deviceInfo
- Publication number
- EP2214769A1 EP2214769A1 EP07849238A EP07849238A EP2214769A1 EP 2214769 A1 EP2214769 A1 EP 2214769A1 EP 07849238 A EP07849238 A EP 07849238A EP 07849238 A EP07849238 A EP 07849238A EP 2214769 A1 EP2214769 A1 EP 2214769A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tube
- chamber
- rotating means
- variable
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/0013—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting fluid pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0069—Sealing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3507—Communication with implanted devices, e.g. external control
- A61M2205/3515—Communication with implanted devices, e.g. external control using magnetic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
- F16K3/00—Gate valves or sliding valves, i.e. cut-off apparatus with closing members having a sliding movement along the seat for opening and closing
- F16K3/30—Details
- F16K3/34—Arrangements for modifying the way in which the rate of flow varies during the actuation of the valve
Definitions
- the present invention concerns an implantable adjustable drainage device for draining body fluids. More specifically, the present invention concerns a non- invasively adjustable drainage device used for example for the treatment of glaucoma.
- Implantable adjustable drainage devices are known in the art, especially in the field of treatment of glaucoma.
- Glaucoma is a disorder associated with high pressure in the eye, and is characterized by damage to the optic nerve, with consequent visual loss, initially peripheral, but potentially blinding if relentlessly progressive.
- glaucoma is usually a disease in which the patient is entirely asymptomatic (without symptoms) until late in the disease. Glaucoma affects about 70 millions of people worldwide.
- GDD glaucoma drainage device
- the GDD is inserted through a small incision made in the conjunctiva.
- the surgeon then makes a tiny incision in the sclera of the eye and fashions an opening for the drainage implant device.
- the drainage tube is placed such that the opening of the tiny tube is inside the anterior chamber of the eye where it is bathed in aqueous fluid.
- the tube is sutured in place with the drainage device attached to the sclera of the eye.
- Most surgeons will place an absorbable suture around the tube at the time of surgery to prevent filtration through the device until a fibrous capsule has formed. As such, the device is not expected to function until about 3 to 8 weeks following the procedure. This technique is thought to prevent over-filtration.
- the Molteno device comprises in particular a tube made of a biologically inert silicone tubing for insertion into the eye in order to drain the aqueous humor from the anterior chamber of the eye.
- This device does not have a pressure regulating mechanism and only relies on the pressure regulation provided by the resistance to aqueous flow of the tubing.
- the system comprises a flexible drainage tube with a time-delay valve-opening structure.
- This structure comprises a ball of biocompatible absorbable material as means of applying a valve-closing squeeze on the tube. As the body fluid gradually dissolve the material of the ball, the valve-closing force of the ball is reduced to create a valve opening condition.
- the valve-opening structure comprises polymer components which either inherently or by reason of special compounding are selectively shrinkable or stretchable to effect opening and/or closure operation of the valve device.
- US 6,077,299 to Adelberg et al. discloses a non-invasively adjustable valve implant for the drainage of aqueous humor in glaucoma.
- An aim of the device disclosed in this patent is to provide an implant with a flow characteristic that can be adjusted in a non-invasive manner. More specifically, this device comprises an implant with an inlet tube that is surgically inserted in the anterior chamber of the eye allowing aqueous humor to flow from the anterior chamber to a valve. After passing through the pressure and/or flow regulating valve in the implant, the fluid is dispersed along the periphery of the implant to the interior of the Tenon's capsule where it is absorbed by the body.
- the valve inhibits flow below and allows flow above a specific pressure difference between the intraocular pressure within the eye and the pressure within the bleb cavity in Tenon's capsule.
- the specified pressure difference or set-point is always positive and the valve is always closed for negative pressure differences to prevent reverse flow of fluid from the Tenon's capsule back into the anterior chamber of the eye.
- the valve is formed by a chamber to which the inlet tube is connected, said chamber being closed by pressure sensitive valve made of a flexible material, such as silicone, in the shape of a flat cone.
- the pressure regulation set point of the valve is governed by a flexible diaphragm cooperating with an armature plate having an inclined surface configured to slide over a complementary inclined surface that is attached to the diaphragm. The cooperation of the inclined surface of the plate and the complementary surface causes the diaphragm to deflect depending on where the armature plate is located.
- the armature plate itself is rotated to carry out this regulation through a rotor and a set of speed-reducing and torque-enhancing gears.
- the characteristics of the valve depend strongly on one element that is the cone shaped valve.
- the regulating mechanism comprises many rotating parts and gears rendering it rather complicated to fabricate.
- US 6,168,575 and US 6,589,198 to Soltanpour et al. disclose micro-pump assemblies that can be implanted in the eye for controllably removing excess fluid from the eye in order to treat glaucoma.
- the implanted pumps have a variable pumping rate that can be adjusted either manually or automatically, controlled by the measured intra-ocular pressure.
- the disadvantage of such device is in particular the fact that they are complicated and expensive. Indeed, the device must contain all the necessary elements, in particular electronics and power source and since the device is implanted, these elements must be small and contained in a sealed enclosure. The risk of malfunction is also increased because of the high number of different elements present that must cooperate together.
- an aim of the present invention is to improve the known devices and system.
- Another aim of the present invention is to provide a GDD device that is simple to operate, using a reduced number of parts.
- a further aim of the present invention is to provide a GDD device that is easy and cheap to fabricate.
- Figure 1 illustrates a first embodiment of the invention
- Figure 2 illustrates an example of an external control device
- FIG. 3 illustrates a second embodiment of the invention
- Figure 4 illustrates a third embodiment of the invention
- Figure 5 illustrates a fourth embodiment of the invention.
- GDD Glaucoma drainage device
- FIG 1 a schematic diagram of first embodiment of the device is represented.
- the principle is to adjust the hydrodynamic resistance of the device by means of a rotating disk, which encompasses a variable-section for the passage of fluid. As the disk rotates, clockwise or counterclockwise, the section increases or decreases and the resistance decreases or increases, respectively.
- the device comprises an inlet tube 1 , which drains the fluid from the eye (or any other part to be drained) into a hollow shallow container 2.
- the container is closed hermetically with a gasket 4, which comprises a variable section slit 5 through which fluid can flow from the exit of the tube 3 into the container and thereafter into the outer space through exit holes 6.
- the gasket 4 although hermetically sealing the container, can rotate around its axis, which is also the axis of rotational symmetry of the container. According to the invention, the rotation of the gasket 4 changes the relative position of the slit 5 with respect to the tube exit 3, thereby imposing a variable resistance to fluid flow.
- the gasket is rotated counterclockwise (viewed from the top)
- the slit section in front of the tube exit 3 decreases, thereby increasing flow resistance
- the rotation is clockwise the slit section increases and resistance to fluid flow decreases.
- the gasket comprises a permanent magnet 7 that creates a magnetic field, which can easily be detected by placing an external device (i.e. a sensing device) on top of the patient's eye.
- the sensing device contains a number of sensors, such as magnetoresistive sensors or other equivalent devices, which can sense the magnetic field.
- the information from the sensors can be combined with the magnetic field equations to derive the amplitude and direction of the magnetic field. This allows the precise determination of the direction of the magnet 7 and, by way of consequence, the rotational position of the gasket 4.
- the user can impose a given rotation to the gasket by applying a strong external magnetic field, which is oriented at a given angle with respect to the actual angle of the magnet 4.
- Magnetoresistive sensors 9 are placed on a rim 8, which is positioned on top of the patient's eye. The sensors are used to capture and compute the direction of the underlying magnet 7, which is displayed as the vector oriented to the left on the control unit 11 screen. If the user wishes to rotate the gasket 4 by an angle ⁇ clockwise, he/she turns the electromagnet 10 such that its direction illustrated by the vector oriented to the right on the control unit 11 screen forms the desired angle ⁇ with the magnet angle. The user then powers the electromagnet 10, which applies a strong magnetic field with a polarity opposite to that of the magnet and in the direction of the vector oriented to the right. The induced magnetic field applies a strong torque on the underlying magnet 7, which forces the magnet 7 to align with the vector oriented to the right, thus achieving the desired gasket rotation.
- the rotational electromagnet 10 can be replaced by two fixed orthogonal electromagnets. Upon activation, each of the two orthogonal electromagnets will deliver a magnetic field oriented along its axis. The total magnetic field will be the vector sum of the two individual fields. By choosing the relative intensity of the current fed into each of the electromagnets one can deliver a magnetic field of any desired magnitude and orientation.
- Fluidic resistance can be measured for the different rotational positions of the gasket, thereby providing some a priori guidance to the user for selecting the amplitude of rotation needed for obtaining a desired effect on the drainage and the resulting lOP. Otherwise, the user may apply incremental rotations and measure every time the IOP for verifying the optimal position of the gasket 4.
- FIG. 3 Another embodiment of the invention is illustrated in Figure 3.
- the tube 12 which is inserted into the intraocular space and acts as fluid conduit is connected to a container 13 either at an normal angle or, in general, at an oblique angle as shown in Figure 3.
- the base of the container 13 in contact with the eye is either flat or has a slight spherical curvature, with a radius of curvature of typically 11 mm or similar, which corresponds to the natural radius of curvature of the eye.
- This curvature is seen in Figure 3C.
- "A” shows an assembled view of this embodiment of the invention.
- "B” an exploded view of the device where the internal plate 17 containing the variable section slit 16 and the magnet 18 is seen.
- C A section view of the tube-container assembly with a longitudinal cut through the tube 12 showing the canal 14 through which fluid flows.
- the change in fluidic resistance is achieved by rotating plate 17 via the rotation imposed on the magnet 18 through the external magnetic field.
- Plate 17 is assembled so that is kept under some pressure against the base of the inner cavity of the container 13 (for example through a spring), leaving thus no space for the fluid to exit from the tube 12 other than through the slit 16.
- the plate 17 has an axis (not shown) which penetrated into a hole of the container 13 to ensure proper relative rotation.
- plate 17 may contain a plurality of holes 21 as opposed to the variable section slit 16.
- the holes have a progressively smaller diameter and are spaced on a circular arc with respect to the axis of rotation in a manner such that as the disk is rotated by a given angle ⁇ , one of the holes 21 will be on top and concentric with the exit hole 15.
- the angle of rotation between two successive holes ⁇ is drawn here to be 30 degrees, but this can vary according to the number of holes and the desired resolution (fine regulation) in the change in fluidic resistance that one likes to achieve.
- the plate 17 may comprise on its axis of rotation or in the periphery a "gear-like" system or equivalent system, which allows rotational steps of exactly the angle ⁇ .
- a "gear-like" system or equivalent system which allows rotational steps of exactly the angle ⁇ .
- FIG 4. An example, among others, of such system is shown in Figure 4.
- the dodecagonal "gear” 22 is concentric and attached to the plate 17.
- the stiff but flexible beam 23 is fixed to the wall of the container 13 and is pushing on one of the flat surfaces of dodecagonal "gear” 22 with a certain force F. Any rotation of the plate 17 less than ⁇ will force the beam to be deflected to the left, increasing thus the contact force F. The contact force F will be restored into its minimum level when a rotation of exactly ⁇ is achieved.
- Such a system guarantees two important functionalities:
- the device according to the invention can include a miniaturized pressure sensor along the fluidic channel 14, preferably as close to the intraocular space as possible, connected to a miniaturized telemetry system which can be activated and energized from distance and which can send to an external receiver, telemetrically, the measured IOP signal.
- a miniaturized pressure sensor along the fluidic channel 14, preferably as close to the intraocular space as possible, connected to a miniaturized telemetry system which can be activated and energized from distance and which can send to an external receiver, telemetrically, the measured IOP signal.
- the principle of the invention i.e. sense the direction of magnetic fields within implanted devices and applying magnetic fields to move or rotate parts of said implanted devices can be of general utility for a variety of medical devices.
- One such example is the control of fluid flow within bodily conduits, such as vessels (veins or arteries) or other ducts (i.e., urinary duct, etc).
- An example of a further embodiment of the invention illustrating this principle is shown in Figure 5.
- the device containing an outer shell 24 connected through a hinge 26 to a clip 25 can be positioned around a vessel 27 so that the vessel is contained in the space between the clip 25 and a flexible and/or elastic membrane 28, which covers hermetically the device and prevents any contact of the internal mechanism of the device with the external fluids and tissues.
- the clip 25 is secured in place by a locking system 31.
- An elliptic-shaped cylinder 30 containing a magnet 29 can be rotated via applied external magnetic fields, as explained earlier, thereby pressing at variable degrees on the membrane 28, depending on its rotational position, and thus imposing variables degrees of constriction on the arterial cross sectional area. This, in turn, will lead to changes in hemodynamical resistance and control of flow.
- the shape of the clip 25 and the rotating elliptic-shaped cylinder 30 can be chosen so as to optimize the effects of rotation on the shape of the contained vessel, to achieve optimal results (i.e., linear or prescribed change in cross-sectional area of the vessel per degree of rotation, etc.).
- this embodiment may be used in the device illustrated in figure 1 whereby the vessel 27 of figure 5 will be replaced by the inlet tube 1 to obtain the same regulation effect. Also, it is possible to use a system equivalent to the gear 22 and beam 23 of figure 4 in order to carry out definite rotation of a given angle instead of continuous variations.
- the gasket could be designed to open one or more exit holes, depending on its angular position and thereby limit or increase the flow of liquid leaving the container.
- the same principle may be applied to the embodiment of figure 3 where one or more exit holes 20 may be opened to limit or increase the flow leaving the container 13.
- a porous media with variable porosities instead of varying the section of the slit or the diameter of the holes, one could envisage to use a porous media with variable porosities.
- all holes could have the same diameter and be covered with a sheath or other biocompatible fabric with different porosity.
- Another possibility is to have a continuous slit of constant width, but have the slit covered with a sheath or fabric or equivalent surface with a gradually changing porosity.
- the change of porosity could be made by the addition of layers, thus reducing the porosity when more layers are present.
- the slit or the holes could also change size even with such porous media added. This could allow a finer regulation of the flow.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11187738A EP2417946A1 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2007/054771 WO2009066133A1 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP11187738.7 Division-Into | 2011-11-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2214769A1 true EP2214769A1 (en) | 2010-08-11 |
| EP2214769B1 EP2214769B1 (en) | 2013-03-13 |
Family
ID=39508864
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP11187738A Withdrawn EP2417946A1 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
| EP07849238A Active EP2214769B1 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP11187738A Withdrawn EP2417946A1 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9375347B2 (en) |
| EP (2) | EP2417946A1 (en) |
| JP (1) | JP5390531B2 (en) |
| CN (1) | CN101918071B (en) |
| ES (1) | ES2410430T3 (en) |
| WO (1) | WO2009066133A1 (en) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6464724B1 (en) | 1999-04-26 | 2002-10-15 | Gmp Vision Solutions, Inc. | Stent device and method for treating glaucoma |
| US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
| US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
| US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
| WO2002080811A2 (en) | 2001-04-07 | 2002-10-17 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| US7331984B2 (en) | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
| WO2008061043A2 (en) | 2006-11-10 | 2008-05-22 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
| WO2012095499A1 (en) | 2011-01-14 | 2012-07-19 | Ecole Polytechnique Fédérale De Lausanne Epfl-Tto | Apparatus and methods for treating excess intraocular fluid |
| US10603214B2 (en) | 2011-01-14 | 2020-03-31 | Ecole Polytechnique Federale De Lausanne (Epfl) | Apparatus and methods for treating excess intraocular fluid |
| EP3342380B1 (en) | 2012-03-26 | 2024-12-04 | Glaukos Corporation | System for delivering multiple ocular implants |
| CA2877544C (en) | 2012-06-21 | 2017-10-17 | Medtronic Xomed, Inc. | Fluid flow control devices, rotors and magnets with increased resistance to inadvertent setting change and improved accessory tool coupling |
| US9126010B2 (en) | 2013-03-14 | 2015-09-08 | Medtronic Xomed, Inc. | Device and method for finding the center and reading the setting of an implantable medical device |
| US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
| US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| CN103919643A (en) * | 2014-04-01 | 2014-07-16 | 齐文华 | Postoperative sclera flap adhesion preventive device for anti-glaucoma operation |
| AU2015266850B2 (en) | 2014-05-29 | 2019-12-05 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| CN104490515A (en) * | 2014-12-18 | 2015-04-08 | 肖真 | Glaucoma valve and glaucoma drainage device |
| US9655778B2 (en) | 2015-07-13 | 2017-05-23 | Thomas D. Tyler | Position responsive flow adjusting implantable device and method |
| WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
| US10596035B2 (en) | 2016-06-06 | 2020-03-24 | Ecole Polytechnique Federale De Lausanne (Epfl) | Apparatus for treating excess intraocular fluid |
| US11351058B2 (en) | 2017-03-17 | 2022-06-07 | W. L. Gore & Associates, Inc. | Glaucoma treatment systems and methods |
| US11166849B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
| WO2019018807A1 (en) | 2017-07-20 | 2019-01-24 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
| EP3681449A1 (en) * | 2017-09-11 | 2020-07-22 | Oregon Health & Science University | Glaucoma tube implant with modulated flow |
| US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
| EP3773377A4 (en) | 2018-04-03 | 2021-12-01 | Jack Chu | NEW EYE DEVICE AND GLAUCOMA TREATMENT METHOD |
| EP3583892A1 (en) * | 2018-06-20 | 2019-12-25 | Koninklijke Philips N.V. | Pressure sensing unit, system and method for remote pressure sensing |
| WO2020047221A1 (en) | 2018-08-29 | 2020-03-05 | W. L. Gore & Associates, Inc. | Drug therapy delivery systems and methods |
| EP3846748B1 (en) | 2018-09-06 | 2026-03-25 | Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO | Apparatus for treating excess intraocular fluid having an elastic membrane |
| US12329682B2 (en) | 2019-01-18 | 2025-06-17 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
| US12551268B2 (en) | 2019-07-08 | 2026-02-17 | Shifamed Holdings, Llc | Minimally invasive bleb formation devices and methods for using such devices |
| CN110522556B (en) * | 2019-08-30 | 2021-07-13 | 华中科技大学同济医学院附属同济医院 | A pre-adjustable electromagnetic drainage valve for the treatment of glaucoma |
| US11517477B2 (en) | 2019-10-10 | 2022-12-06 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
| WO2021151007A1 (en) | 2020-01-23 | 2021-07-29 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
| CN115426988A (en) | 2020-02-14 | 2022-12-02 | 施菲姆德控股有限责任公司 | Flow diversion systems having rotation-based flow control assemblies, and related systems and methods |
| EP4106695A4 (en) | 2020-02-18 | 2024-03-20 | Shifamed Holdings, LLC | Adjustable flow glaucoma shunts having non-linearly arranged flow control elements, and associated systems and methods |
| WO2021176332A1 (en) | 2020-03-06 | 2021-09-10 | Ecole Polytechnique De Lausanne (Epfl) | Apparatus for treating excess intraocular fluid having an elastic membrane |
| US11766355B2 (en) | 2020-03-19 | 2023-09-26 | Shifamed Holdings, Llc | Intraocular shunts with low-profile actuation elements and associated systems and methods |
| JP7743435B2 (en) | 2020-04-16 | 2025-09-24 | シファメド・ホールディングス・エルエルシー | Adjustable Glaucoma Treatment Device and Associated Systems and Methods |
| JP7579594B2 (en) | 2020-05-15 | 2024-11-08 | アイフロー・インコーポレーテッド | Methods and devices for implantation within conventional aqueous humor drainage channels of the mammalian eye |
| CN111425687A (en) * | 2020-05-16 | 2020-07-17 | 邵阳学院 | Erosion-resistant fluid pressure reduction device with adjustable opening degree |
| WO2022159723A1 (en) | 2021-01-22 | 2022-07-28 | Shifamed Holdings, Llc | Adjustable shunting systems with plate assemblies, and associated systems and methods |
| US12527691B2 (en) | 2021-11-05 | 2026-01-20 | W. L. Gore & Associates, Inc. | Fluid drainage devices, systems, and methods |
| WO2023081356A1 (en) * | 2021-11-05 | 2023-05-11 | W. L. Gore & Associates, Inc. | Fluid drainage devices, systems, and methods |
| US12544262B2 (en) | 2021-11-05 | 2026-02-10 | W. L. Gore & Associates, Inc. | Fluid drainage devices, systems, and methods |
| WO2023081365A1 (en) * | 2021-11-05 | 2023-05-11 | W. L. Gore & Associates, Inc. | Fluid drainage devices, systems, and methods |
| WO2024165744A1 (en) * | 2023-02-10 | 2024-08-15 | Universiteit Maastricht | An implantable ocular drainage device for controlling intraocular pressure |
| CN116793436A (en) * | 2023-06-27 | 2023-09-22 | 浙江大学 | Variable viscous flow resistance structure |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3926175A (en) * | 1974-06-03 | 1975-12-16 | James H Allen | Implantable valve for medical purposes |
| DE2626215C3 (en) * | 1976-06-11 | 1979-03-01 | Messerschmitt-Boelkow-Blohm Gmbh, 8000 Muenchen | Drainage device for draining excess fluid from the cerebral cavities |
| US4140011A (en) * | 1977-05-31 | 1979-02-20 | The Regents Of The University Of Minnesota | Automatic precipitation sampler |
| US4457757A (en) | 1981-07-20 | 1984-07-03 | Molteno Anthony C B | Device for draining aqueous humour |
| US4515588A (en) * | 1983-05-16 | 1985-05-07 | Health Care Concepts, Inc. | I.V. flow regulator |
| US5071408A (en) | 1988-10-07 | 1991-12-10 | Ahmed Abdul Mateen | Medical valve |
| US5300020A (en) | 1991-05-31 | 1994-04-05 | Medflex Corporation | Surgically implantable device for glaucoma relief |
| US5308040A (en) * | 1991-11-28 | 1994-05-03 | Torres Nestor Ruben | Fluid flow regulating valve |
| GB2285303B (en) * | 1993-12-31 | 1997-07-23 | Hwang Shao Keh | Magnetic control-type flow control valve |
| US5626558A (en) | 1995-05-05 | 1997-05-06 | Suson; John | Adjustable flow rate glaucoma shunt and method of using same |
| GB9700390D0 (en) | 1997-01-10 | 1997-02-26 | Biocompatibles Ltd | Device for use in the eye |
| US6168575B1 (en) | 1998-01-29 | 2001-01-02 | David Pyam Soltanpour | Method and apparatus for controlling intraocular pressure |
| US6589198B1 (en) | 1998-01-29 | 2003-07-08 | David Soltanpour | Implantable micro-pump assembly |
| US6050969A (en) * | 1998-04-17 | 2000-04-18 | Johnson & Johnson Professional, Inc. | Pressure indicator |
| US6090062A (en) * | 1998-05-29 | 2000-07-18 | Wayne State University | Programmable antisiphon shunt system |
| US6077299A (en) * | 1998-06-22 | 2000-06-20 | Eyetronic, Llc | Non-invasively adjustable valve implant for the drainage of aqueous humor in glaucoma |
| US6558342B1 (en) | 1999-06-02 | 2003-05-06 | Optonol Ltd. | Flow control device, introducer and method of implanting |
| JP3852734B2 (en) | 1999-12-20 | 2006-12-06 | セイコーインスツル株式会社 | Pressure variable valve device and set pressure adjusting device for the valve device |
| US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
| DE10113823A1 (en) | 2001-03-21 | 2002-09-26 | Seiko Instr Inc | Pressure control valve device and device for setting the desired pressure of the valve |
| EP1386634B1 (en) * | 2002-08-02 | 2005-10-19 | Medos SA | Cerebrospinal fluid shunt system incorporating an adjustable resistance valve |
| JP4328688B2 (en) | 2004-07-26 | 2009-09-09 | 株式会社カネカメディックス | Subcutaneous body fluid flow controller |
| US7093818B2 (en) * | 2004-08-03 | 2006-08-22 | Harris Corporation | Embedded control valve using homopolar motor |
| US7334594B2 (en) * | 2005-06-29 | 2008-02-26 | Codman & Shurtleff, Inc. | Apparatus and method for adjusting a locking mechanism of a shunt valve |
| JP5378203B2 (en) * | 2006-04-07 | 2013-12-25 | ネクステージ メディカル インコーポレイテッド | Filtration system to make medical fluid |
| WO2007127305A2 (en) | 2006-04-26 | 2007-11-08 | Eastern Virginia Medical School | Systems and methods for monitoring and controlling internal pressure of an eye or body part |
| WO2008027597A2 (en) * | 2006-08-31 | 2008-03-06 | Smartin Technologies, Llc | Implantable fluid pump |
| WO2008061043A2 (en) * | 2006-11-10 | 2008-05-22 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
-
2007
- 2007-11-23 JP JP2010534553A patent/JP5390531B2/en not_active Expired - Fee Related
- 2007-11-23 EP EP11187738A patent/EP2417946A1/en not_active Withdrawn
- 2007-11-23 ES ES07849238T patent/ES2410430T3/en active Active
- 2007-11-23 EP EP07849238A patent/EP2214769B1/en active Active
- 2007-11-23 CN CN200780101682.3A patent/CN101918071B/en not_active Expired - Fee Related
- 2007-11-23 WO PCT/IB2007/054771 patent/WO2009066133A1/en not_active Ceased
- 2007-11-23 US US12/743,955 patent/US9375347B2/en active Active
-
2016
- 2016-02-09 US US15/019,890 patent/US20160287439A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2009066133A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011504392A (en) | 2011-02-10 |
| ES2410430T3 (en) | 2013-07-01 |
| EP2214769B1 (en) | 2013-03-13 |
| US20110066098A1 (en) | 2011-03-17 |
| CN101918071A (en) | 2010-12-15 |
| US9375347B2 (en) | 2016-06-28 |
| EP2417946A1 (en) | 2012-02-15 |
| JP5390531B2 (en) | 2014-01-15 |
| US20160287439A1 (en) | 2016-10-06 |
| CN101918071B (en) | 2016-11-16 |
| WO2009066133A1 (en) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2214769B1 (en) | Non-invasively adjustable drainage device | |
| US12589030B2 (en) | Apparatus and methods for treating excess intraocular fluid | |
| JP6330014B2 (en) | Apparatus and method for treating excess intraocular fluid | |
| US12274643B2 (en) | Apparatus for treating excess intraocular fluid having an elastic membrane | |
| EP3463227B1 (en) | Apparatus for treating excess intraocular fluid | |
| US11779489B2 (en) | Apparatus for treating excess intraocular fluid having an elastic membrane | |
| Villamarin et al. | A new adjustable glaucoma drainage device | |
| CN105919723A (en) | Non-invasive adjustable drainage equipment | |
| WO2025146618A1 (en) | Systems and methods for treating excess pressure having an elastic membrane in fluid contact with bodily fluid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20100623 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20110510 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61M 27/00 20060101ALN20120105BHEP Ipc: A61F 9/007 20060101AFI20120105BHEP |
|
| GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAC | Information related to communication of intention to grant a patent modified |
Free format text: ORIGINAL CODE: EPIDOSCIGR1 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61F 9/007 20060101AFI20120827BHEP Ipc: A61M 27/00 20060101ALN20120827BHEP |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 600348 Country of ref document: AT Kind code of ref document: T Effective date: 20130315 Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602007029115 Country of ref document: DE Effective date: 20130502 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ANDRE ROLAND CONSEILS EN PROPRIETE INTELLECTUE, CH |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2410430 Country of ref document: ES Kind code of ref document: T3 Effective date: 20130701 |
|
| RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) EP |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130613 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 600348 Country of ref document: AT Kind code of ref document: T Effective date: 20130313 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130614 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130715 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130713 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| 26N | No opposition filed |
Effective date: 20131216 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007029115 Country of ref document: DE Effective date: 20131216 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20071123 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130313 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20231120 Year of fee payment: 17 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231123 Year of fee payment: 17 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20231124 Year of fee payment: 17 Ref country code: FR Payment date: 20231120 Year of fee payment: 17 Ref country code: DE Payment date: 20231121 Year of fee payment: 17 Ref country code: CH Payment date: 20231201 Year of fee payment: 17 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240126 Year of fee payment: 17 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602007029115 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20241201 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20241123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241130 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241201 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20250603 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241130 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20260105 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241124 |